Health
Pfizer to Seek FDA Approval for COVID-19 Vaccine After Election – Latin Post
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
Pfizer said their company will not ask for Food and Drug Administration (FDA) approval for their COVID-19 vaccine candidate until after the election.
As Pfizer CEO Albert Bourla said in an open letter, their COVID-19 vaccine cannot request for emergency FDA approval before the third week of November.
The timeline is only based on Pfizer’s best estimates and does not account for delays on the COVID-19 vaccine, said an Associated Press report.
Bourla said that if they do ask for FDA approval, t…
-
Noosa News10 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General10 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Business13 hours agoTime to buy before it’s too late?
-
General19 hours agoFormer Marine Paul Doyle pleads guilty to Liverpool FC parade car ramming charges